The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.
Open Access
- 1 September 1992
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 90 (3) , 897-905
- https://doi.org/10.1172/jci115965
Abstract
Although Escherichia coli strains possessing the K1 capsule are predominant among isolates from neonatal E. coli meningitis and most of these K1 isolates are associated with a limited number of 0 lipopolysaccharide (LPS) types, the basis of this association of K1 and certain 0 antigens with neonatal E. coli meningitis is not clear. The present study examined in experimental E. coli bacteremia and meningitis in newborn and adult rats whether or not the K1 capsule and/or O-LPS antigen are critical determinants in the development of meningitis. Rats received subcutaneously at K1 E. coli strain (018+K1+) or mutants lacking either the K1 capsule (018+K1-) or 0 side-chain (018-K1+). 12-24 h later, blood and cerebrospinal fluid (CSF) specimens were obtained for quantitative cultures. The isolation of E. coli from CSF was observed in both newborn and adult rats infected with K1+ strains regardless of LPS phenotype (018+ or 18-) who also developed a high degree of bacteremia (e.g., greater than 10(4) CFU/ml of blood). In contrast, none of the newborn and adult rats infected with 018+K1- and developing bacteremia of greater than 10(4) were found to have positive CSF cultures. These findings indicate that the presence of the K1 capsule and a high degree of bacteremia are key determinants in the development of E. coli meningitis, suggesting that there may be specific binding sites present in the brain which have an affinity for the K1 capsule and thus may be responsible for the entry of K1-encapsulated E. coli into the meninges. Images.Keywords
This publication has 32 references indexed in Scilit:
- Functional Activities of Monoclonal Antibodies to the O Side Chain of Escherichia coli Lipopolysaccharides in Vitro and in VivoThe Journal of Infectious Diseases, 1988
- Efficacy of Human Immunoglobulin and Penicillin G in Treatment of Experimental Group B Streptococcal InfectionPediatric Research, 1987
- Role of Lipopolysaccharide and Capsule in the Serum Resistance of Bacteremic Strains of Escherichia coliThe Journal of Infectious Diseases, 1986
- Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitisAntimicrobial Agents and Chemotherapy, 1985
- Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococciAntimicrobial Agents and Chemotherapy, 1985
- Restricted Complement Activation by Escherichia Coli with the K-1 Capsular Serotype: A Possible Role in PathogenicityThe Journal of Immunology, 1978
- Current Topics in Host Defenses of the NewbornAdvances in Pediatrics, 1978
- Serology, chemistry, and genetics of O and K antigens of Escherichia coli.1977
- Bacterial Meningitis in the Newborn InfantClinics in Perinatology, 1977
- STUDIES ON THE PATHOGENESIS OF MENINGITIS. II. DEVELOPMENT OF MENINGITIS DURING PNEUMOCOCCAL BACTEREMIA*Journal of Clinical Investigation, 1962